First human tests begin for potential ulcerative colitis drug
Knowledge-focused
Recruiting now
This is a very early, first-in-human study to check the basic safety of a new drug called ALTB-268, which is being developed for ulcerative colitis. It will be given as a single intravenous dose to 24 healthy volunteers to see how their bodies react to it and process it. The main…
Phase: PHASE1 • Sponsor: AltruBio Inc. • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC